184 related articles for article (PubMed ID: 21097877)
21. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
23. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
[TBL] [Abstract][Full Text] [Related]
24. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation].
Hamza M; Meddeb S; Mili I; Ouertani A
Ann Med Interne (Paris); 1992; 143(7):438-41. PubMed ID: 1300863
[TBL] [Abstract][Full Text] [Related]
25. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
Sfikakis PP; Theodossiadis PG; Katsiari CG; Kaklamanis P; Markomichelakis NN
Lancet; 2001 Jul; 358(9278):295-6. PubMed ID: 11498218
[TBL] [Abstract][Full Text] [Related]
26. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
27. Infliximab in the treatment of refractory posterior uveitis.
Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
[TBL] [Abstract][Full Text] [Related]
28. Infliximab for chronic cystoid macular edema associated with uveitis.
Markomichelakis NN; Theodossiadis PG; Pantelia E; Papaefthimiou S; Theodossiadis GP; Sfikakis PP
Am J Ophthalmol; 2004 Oct; 138(4):648-50. PubMed ID: 15488796
[TBL] [Abstract][Full Text] [Related]
29. Induction of regulatory T cells by infliximab in Behcet's disease.
Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
[TBL] [Abstract][Full Text] [Related]
30. [Uveitic cystoid macular edema: intravitreal triamcinolone].
Feucht M; Sturm V; Weissmann J; Richard G; Pressmar S
Klin Monbl Augenheilkd; 2007 Jan; 224(1):62-5. PubMed ID: 17260323
[TBL] [Abstract][Full Text] [Related]
31. [Intravitreal injection of triamcinolone acetonide in non infectious uveitis].
Benítez Del Castillo Sánchez JM; García Sánchez J
Arch Soc Esp Oftalmol; 2001 Nov; 76(11):661-4. PubMed ID: 11715104
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
Ozkiris A
Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease.
Kramer M; Ehrlich R; Snir M; Friling R; Mukamel M; Weinberger D; Axer-Siegel R
Am J Ophthalmol; 2004 Oct; 138(4):666-7. PubMed ID: 15488806
[TBL] [Abstract][Full Text] [Related]
34. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
35. Retrospective case review of pediatric patients with uveitis treated with infliximab.
Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
[TBL] [Abstract][Full Text] [Related]
36. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
38. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
39. Deep intramuscular methylprednisolone for the treatment of cystoid macular oedema in uveitis.
Tehrani NN; Saeed T; Murray PI
Eye (Lond); 2000 Oct; 14 Pt 5():691-4. PubMed ID: 11116686
[TBL] [Abstract][Full Text] [Related]
40. Vitrectomy for persistent panuveitis in Behçet's disease.
Ahn JK; Chung H; Yu HG
Ocul Immunol Inflamm; 2005 Dec; 13(6):447-53. PubMed ID: 16321889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
